Uveal Melanoma: Refusal of Treatment

Randy Christopher Bowen, Soto Hansell, Vishal Raval, Jacquelyn M. Davanzo, Arun D. Singh*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Purpose: This study aimed to explore factors for refusing treatment in patients diagnosed with uveal melanoma and their subsequent clinical course. Methods: This study included patients with uveal melanoma who refused standard of care treatment. Patient-reported reasons and pre-existing mental health diagnoses were assessed. The sociodemographic profile was compared with the controls. Ocular survival, metastasis-free survival (MFS), and overall survival (OS) were calculated. Results: Nine patients with uveal melanoma declined ocular treatment (plaque brachytherapy, n = 7 [78%]; enucleation, n = 2 [22%]). The choroidal melanomas were small (n = 1 [11%]), medium (n = 5 [56%]), and large (n = 3 [33%]) in size (COMS criteria). The sociodemographic profile of the study patients was not different from those that accepted treatment. One patient (11%) had pre-existing mental health diagnosis. Five patients (56%) eventually accepted treatment following an average delay of 19 months (range: 4-55 months) due to neovascular glaucoma or severe vision loss. MFS could not be ascertained, and OS was 67% (6/9) at 4.2 years of follow-up (mean). Conclusions: Refusal of initial recommended treatment is associated with poor ocular survival. The small sample size did not allow for an evaluation of the impact on survival.

Original languageEnglish (US)
Pages (from-to)361-367
Number of pages7
JournalOcular Oncology and Pathology
Issue number5
StatePublished - Oct 1 2021


  • Choroidal melanoma
  • Refusal of care
  • Sociodemographic profile
  • Uveal melanoma

ASJC Scopus subject areas

  • General Nursing


Dive into the research topics of 'Uveal Melanoma: Refusal of Treatment'. Together they form a unique fingerprint.

Cite this